Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20190717002Phase 3Completed
A Phase 3 trial of budesonide in chronic rhinosinusitis (CRS), sponsored by none. Started Feb 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20190717002.